Cargando…
Combined immune checkpoint protein blockade and low dose whole body irradiation as immunotherapy for myeloma
BACKGROUND: Multiple myeloma is characterized by the presence of transformed neoplastic plasma cells in the bone marrow and is generally considered to be an incurable disease. Successful treatments will likely require multi-faceted approaches incorporating conventional drug therapies, immunotherapy...
Autores principales: | Jing, Weiqing, Gershan, Jill A, Weber, James, Tlomak, Dominique, McOlash, Laura, Sabatos-Peyton, Catherine, Johnson, Bryon D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302511/ https://www.ncbi.nlm.nih.gov/pubmed/25614821 http://dx.doi.org/10.1186/s40425-014-0043-z |
Ejemplares similares
-
Adoptive cell therapy using PD-1(+) myeloma-reactive T cells eliminates established myeloma in mice
por: Jing, Weiqing, et al.
Publicado: (2017) -
Changes in immune checkpoint protein expression on CD8 T cells during neoadjuvant therapy in patients with pancreatic cancer
por: Tsai, Susan, et al.
Publicado: (2014) -
Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models
por: Tsai, Susan, et al.
Publicado: (2018) -
Immune modulating effects of cyclophosphamide and treatment with tumor lysate/CpG synergize to eliminate murine neuroblastoma
por: Gershan, Jill A., et al.
Publicado: (2015) -
Cyclophosphamide in combination with tumor lysate and TLR9 ligand regresses murine neuroblastoma
por: Gershan, Jill, et al.
Publicado: (2013)